What is the first line treatment for adrenal insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Adrenal Insufficiency

The first-line treatment for adrenal insufficiency is hydrocortisone (15-25 mg daily) in divided doses, combined with fludrocortisone (50-200 μg daily) for patients with primary adrenal insufficiency. 1

Glucocorticoid Replacement

Glucocorticoid replacement is the cornerstone of adrenal insufficiency treatment:

  • Hydrocortisone is the preferred glucocorticoid replacement:

    • Typical dosage: 15-25 mg/day 1, 2
    • Standard regimen: Three divided doses (e.g., 10 mg on awakening, 5 mg at noon, 2.5 mg in late afternoon) 1
    • Two-dose regimen alternative: 15 mg + 5 mg or 10 mg + 10 mg 1
  • Cortisone acetate is an alternative:

    • Typical dosage: 25-37.5 mg/day
    • Requires activation to hydrocortisone by hepatic 11β-hydroxysteroid dehydrogenase type 1 1
  • Prednisolone (3-5 mg daily) may be considered in select cases:

    • For patients with compliance issues
    • For those experiencing marked fluctuations in energy levels
    • When hydrocortisone/cortisone acetate is not tolerated 1, 2

Mineralocorticoid Replacement

For primary adrenal insufficiency only (not needed in secondary adrenal insufficiency):

  • Fludrocortisone: 50-200 μg once daily upon awakening 1
    • Higher doses (up to 500 μg daily) sometimes needed in children, younger adults, or during pregnancy 1
    • Dose should be adjusted based on:
      • Blood pressure (supine and standing)
      • Presence of peripheral edema
      • Serum potassium levels
      • Salt cravings or lightheadedness

Monitoring Treatment Efficacy

Clinical assessment is the primary method for monitoring glucocorticoid replacement:

  • Signs of over-replacement: Weight gain, insomnia, peripheral edema
  • Signs of under-replacement: Lethargy, nausea, poor appetite, weight loss, increased pigmentation 1

Fine-tuning of dosage should be based on:

  • Patient's weight
  • Energy levels throughout the day
  • Mental concentration
  • Daytime somnolence
  • Changes in pigmentation
  • Sleep patterns 1

Special Considerations

  1. Morning symptoms: For patients with nausea/vomiting in the morning, consider waking earlier to take the first dose, then returning to sleep 1

  2. Medication interactions:

    • Drugs that may increase hydrocortisone requirements: Anti-epileptics, barbiturates, antituberculosis drugs, etomidate, topiramate 1
    • Substances that may decrease hydrocortisone requirements: Grapefruit juice, licorice 1
    • Drugs to avoid with fludrocortisone: Diuretics, acetazolamide, carbenoxolone, NSAIDs 1
  3. Adrenal androgen replacement:

    • Consider DHEA (25 mg daily) for women with persistent low libido or energy levels despite optimized glucocorticoid and mineralocorticoid replacement 1
    • Monitor DHEAS, androstenedione, and testosterone levels 1
  4. Patient education:

    • Patients should carry a steroid card and wear a medical alert bracelet 1
    • Instruction on stress dosing during illness is essential to prevent adrenal crisis 1, 2
    • Unrestricted sodium intake is recommended; avoid potassium-containing salt substitutes 1

Adrenal Crisis Prevention

All patients with adrenal insufficiency should:

  • Be educated about increasing glucocorticoid doses during illness or stress
  • Have injectable hydrocortisone available for emergency use
  • Be trained in parenteral hydrocortisone administration 2, 3

Failure to provide adequate glucocorticoid coverage during stress can lead to life-threatening adrenal crisis, characterized by hypotension, shock, hyponatremia, and altered mental status 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adrenal insufficiency.

Lancet (London, England), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.